Biomarker of asbestos exposure and mesothelioma

Robert Auerbach, Nasim Akhtar, Rachel L Lewis, Brenda L Shinners, Angiogenesis assays: problems and pitfalls. Cancer and Metastasis Reviews. ,vol. 19, pp. 167- 172 ,(2000) , 10.1023/A:1026574416001

U. Rüther, B. Müller-Hill, Easy identification of cDNA clones. The EMBO Journal. ,vol. 2, pp. 1791- 1794 ,(1983) , 10.1002/J.1460-2075.1983.TB01659.X

María del Mar Lorenzo, Rafael Blasco, PCR-Based Method for the Introduction of Mutations in Genes Cloned and Expressed in Vaccinia Virus BioTechniques. ,vol. 24, pp. 308- 313 ,(1998) , 10.2144/98242RR03

Barry A. Morgan, James A. Gainor, Chapter 26. Approaches to the Discovery of Non-Peptide Ligands for Peptide Receptors and Peptidases Annual Reports in Medicinal Chemistry. ,vol. 24, pp. 243- 252 ,(1989) , 10.1016/S0065-7743(08)60548-5

Marco E. Bianchi, Haining Yang, Michele Carbone, Treatment and prevention of cancer with HMGB1 antagonists ,(2012)

Lawrence B. Hendry, Design of drugs involving receptor-ligand-DNA interactions ,(1994)

Bruce A Beutler, David F Crawford, Karsten Peppel, Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells ,(1992)

Kathleen R. Lamborn, Claude F. Meares, Carol M Richman, Gao Ren Zhong, Linda A. Kroger, Sally J. DeNardo, Gerald L Denardo, Laird A. Miers, Qansy Salako, James J. Peterson, Sui Shen, Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts. Clinical Cancer Research. ,vol. 4, pp. 2483- 2490 ,(1998)

Marco E. Bianchi, Bernard Degryse, Paola Scaffidi, Tiziana Bonaldi, Susanne Mueller, Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases ,(2002)

Pieter R. Cullis, Lawrence D. Mayer, Nancy L. Boman, Marcel B. Bally, Liposomal compositions for enhanced retention of bioactive agents ,(1993)